Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Total monthly reach
Estimated from 2 chart positions in 2 markets.
By chart position
- 🇦🇺AU · Medicine#1615K to 30K
- 🇵🇹PT · Medicine#783K to 10K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
4K to 20K🎙 Weekly cadence·20 episodes·Last published 2mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
8K to 40K🇦🇺75%🇵🇹25% - Active Followers
Loyal subscribers who consistently listen
3.2K to 16K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
Recent episodes
Dr. Alex Richardson: Pioneering Clinical Research into Food and Mental Health
Mar 27, 2026
Unknown duration
Dr. Ryan Bradley: Transforming Cardiometabolic Health with Personalised Lifestyle Medicine
Nov 18, 2025
Unknown duration
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Description | Length | |
|---|---|---|---|---|
| 3/27/26 |  Dr. Alex Richardson: Pioneering Clinical Research into Food and Mental Health | This remarkable conversation with Dr. Alex Richardson covers the development of her research that was some of the first to demonstrate the influence of food and nutrition on mood and behaviour. Dr. Richardson has been hugely influential in putting nutrition for mental health on the map, especially in areas such as dyslexia, dyspraxia, ADHD, depression and schizophrenia. From genetics, biochemistry, and nutrition to physiological and psychological functioning, we explore diverse themes relevant to everyone. About our guest: Dr Alex Richardson is a world-renowned researcher, educator, speaker and published author; and the Founder Trustee and Scientific Director of the UK-based charity, Food and Behaviour (FAB) Research. Based at the University of Oxford for 30 years, the impact of her 90+ peer-reviewed publications places Dr Richardson in the top 3% of academic researchers worldwide. In addition to her work for FAB, she is currently a Visiting Research Fellow at the University of Bournemouth, Research Consultant for the Centre of Nutrition and Behaviour at the Rotherham, Doncaster and South Humberside NHS Trust, and research collaborator with the Dept of Psychology at the University of Swansea. Alex is best known for her research into how nutrition (particularly fatty acids) can affect behaviour, learning and mood, as her pioneering clinical trials were the first to show that dietary supplementation with omega-3 (and omega-6) fats can improve behaviour and learning in children with dyslexia, dyspraxia, ADHD and related conditions; and that this approach may also help many other children without such diagnoses. She also published some of the earliest reports of successful nutritional approaches to both depression and schizophrenia in young adults, which have subsequently been confirmed and extended by others. Her work has always been highly inter-disciplinary and collaborative, involving several large-scale collaborative programmes that include studies of epidemiology, genetics, brain imaging, biochemistry and nutrition as well as physiological and psychological functioning. Her main interests centre on the role of nutrition in brain health, and its implications for behaviour, learning and mood, particularly in relation to: neurodevelopment, mental health, links between mental and physical health. Alex's research has also always been primarily aimed at developing new methods of identification and management that will have real practical benefit. In addition to her role as a founder director of FAB Research, she also helped to found the Dyslexia Research Trust, was a co-opted Trustee and Scientific Advisor to the Dyspraxia Foundation, served on the Biomedical Research Committee of Autism Unravelled, and liaised closely with the Hyperactive Children's Support Group, among many others. Guest websites and links: https://www.fabresearch.org Selection of our guest's publications: Montgomery P, Burton JR, Sewell RP, Spreckelsen TF, Richardson AJ. Fatty acids and sleep in UK children: subjective and pilot objective sleep results from the DOLAB study--a randomized controlled trial. J Sleep Res. 2014 Aug;23(4):364-88. Richardson AJ, Burton JR, Sewell RP, Spreckelsen TF, Montgomery P. Docosahexaenoic acid for reading, cognition and behavior in children aged 7-9 years: a randomized, controlled trial (the DOLAB Study). PLoS One. 2012;7(9):e43909. Richardson A. They Are What You Feed Them: How Food Can Improve Your Child's Behaviour, Learning and Mood. Harper. 2010. Cyhlarova E, Montgomery P, Ross MA, Richardson AJ. Niacin skin test response in dyslexia. Prostaglandins Leukot Essent Fatty Acids. 2007 Aug;77(2):123-8. Richardson AJ, Puri BK. A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties. Prog Neuropsychopharmacol Biol Psychiatry. 2002 Feb;26(2):233-9. | — | |
| 11/18/25 |  Dr. Ryan Bradley: Transforming Cardiometabolic Health with Personalised Lifestyle Medicine | Cardiometabolic disorders are the leading cause of morbidity and mortality yet can largely be prevented with diet and lifestyle medicine. Why is there a gap between this epidemic and more effective treatment? Dr. Bradley discusses his clinical research on feasible, cost-effective, efficacious interventions and wider topics around personalised whole person care and 'disruptive innovation' for health promotion. Guest: Dr. Ryan Bradley, ND, MPH About our guest: Dr. Bradley is an Associate Professor in the University of California, San Diego Herbert Wertheim School of Public Health and Human Longevity Science in La Jolla, CA. His commitment to research is to improve the health of the public through rigorous research on non-drug treatments. Dr. Bradley received his ND in naturopathic medicine from Bastyr University in 2003, and his MPH in Epidemiology from the University of Washington in 2009. He completed NIH-funded T32 research training in complementary medicine at Bastyr University and KL2 training in clinical research at the University of Washington in the Division of Cardiology. His research interests include clinical trials of natural products and mind-body therapies in chronic inflammatory conditions including heart disease, type 2 diabetes, pain, and inflammatory bowel disease, plus cardiovascular epidemiology related to natural products, e.g., cannabis, and heart disease risk. Dr. Bradley has conducted a wide-variety of clinical and observational research, including: cardiovascular epidemiology in the Multi-Ethnic Study of Atherosclerosis (MESA) cohort; observational research and clinical trials on practice outcomes from integrating naturopathic medicine and conventional medicine for type 2 diabetes and cardiovascular disease; clinical trials of natural products (including vitamin D, marine oils, xanthohumol, mixed-carotenoids, and quercetin) and mind-body interventions including qigong for type 2 diabetes. He has published in leading peer-reviewed medical journals including: Journal of Alzheimer's Disease, Aging, Atherosclerosis, the Canadian Medical Association Journal, and the Journal of Clinical Endocrinology and Metabolism. Guest websites and links: https://www.researchgate.net/profile/Ryan-Bradley-7 Selection of our guest's publications: Harnett JE, Rickwood C, Steel A, Bradley R. Naturopathic practitioners' approach to caring for people with cardiovascular disease risk factors: A cross-cultural cross-sectional study reporting the providers perspective. Complement Ther Clin Pract. 2022 Feb;46:101511. Anderson CAM, Bradley R. The potential of novel plant protein foods to improve dietary patterns and markers of cardiovascular health. Am J Clin Nutr. 2020 Nov 11;112(5):1151-1152. Steel A, Rickwood C, Bradley R, Foley H, Harnett JE. Australian Naturopaths' Approach to Caring for People with Cardiovascular Disease and Associated Risk Factors: A Qualitative Study of the Providers' Perspective. J Altern Complement Med. 2020 Oct;26(10):902-910. Bradley R, Harnett J, Cooley K, McIntyre E, Goldenberg J, Adams J. Naturopathy as a Model of Prevention-Oriented, Patient-Centred Primary Care: A Disruptive Innovation in Health Care. Medicina (Kaunas). 2019 Sep 18;55(9):603. doi: 10.3390/medicina55090603. PMID: 31540415; PMCID: PMC6780388. Seely D, Szczurko O, Cooley K, Fritz H, Aberdour S, Herrington C, Herman P, Rouchotas P, Lescheid D, Bradley R, Gignac T, Bernhardt B, Zhou Q, Guyatt G. Naturopathic medicine for the prevention of cardiovascular disease: a randomized clinical trial. CMAJ. 2013 Jun 11;185(9):E409-16. Neuendorf R, Corn J, Hanes D, Bradley R. Impact of Food Immunoglobulin G-Based Elimination Diet on Subsequent Food Immunoglobulin G and Quality of Life in Overweight/Obese Adults. J Altern Complement Med. 2019 Feb;25(2):241-248. Bradley R, Sherman KJ, Catz S, Calabrese C, Oberg EB, Jordan L, Grothaus L, Cherkin D. Adjunctive naturopathic care for type 2 diabetes: patient-reported and clinical outcomes after one year. BMC Complement Altern Med. 2012 Apr 18;12:44. doi: 10.1186/1472-6882-12-44. | — |
Showing 2 of 2
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
2 placements across 2 markets.
Chart Positions
2 placements across 2 markets.